Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3486068

Documents

In Collections

This item can be found in the following collections:

Osanto, S.; Woei-A-Jin, F.J.S.H.; Coenraad, M.J.; Weijl, N.I.; Burgmans, M.C.; Burggraaf, J. (2022)

In reply: neoadjuvant TKI study in early- and intermediate stage hepatocellular carcinoma

Article / Letter to editor
This letter to the editor responds to comments from Rizzo et al on recently reported results of a phase II study of dovitinib therapy for hepatocellular carcinoma.
All authors
Osanto, S.; Woei-A-Jin, F.J.S.H.; Coenraad, M.J.; Weijl, N.I.; Burgmans, M.C.; Burggraaf, J.
Date
2022-10-21
Journal
The Oncologist
Volume
27
Issue
12
Pages
e977 - e978
DOI
doi:10.1093/oncolo/oyac215